➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Boehringer Ingelheim
Colorcon
Harvard Business School
McKesson

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SPRYCEL

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Sprycel

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00162214 ↗ Study of Dasatinib in Patients With Advanced Solid Tumors Terminated Bristol-Myers Squibb Phase 1 2005-08-01 The purpose of Segment 1 of the study is to determine the effect of ketoconazole on dasatinib. The purpose of Segment 2 is to learn how dasatinib affects tumor growth in patients with advanced solid tumors.
NCT00255346 ↗ Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) Active, not recruiting Bristol-Myers Squibb Phase 2 2005-11-01 The goal of this clinical research study is to learn if dasatinib can help to control myeloproliferative disorders. The safety and tolerability of dasatinib will also be studied.
NCT00255346 ↗ Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) Active, not recruiting M.D. Anderson Cancer Center Phase 2 2005-11-01 The goal of this clinical research study is to learn if dasatinib can help to control myeloproliferative disorders. The safety and tolerability of dasatinib will also be studied.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sprycel

Condition Name

Condition Name for Sprycel
Intervention Trials
Chronic Myeloid Leukemia 4
Breast Cancer 4
Leukemia 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sprycel
Intervention Trials
Leukemia 30
Leukemia, Myeloid 21
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sprycel

Trials by Country

Trials by Country for Sprycel
Location Trials
United States 165
Spain 12
Japan 11
France 9
China 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sprycel
Location Trials
Texas 18
New York 10
Pennsylvania 10
North Carolina 9
Florida 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sprycel

Clinical Trial Phase

Clinical Trial Phase for Sprycel
Clinical Trial Phase Trials
Phase 4 2
Phase 3 5
Phase 2 31
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sprycel
Clinical Trial Phase Trials
Completed 19
Not yet recruiting 14
Recruiting 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sprycel

Sponsor Name

Sponsor Name for Sprycel
Sponsor Trials
Bristol-Myers Squibb 27
M.D. Anderson Cancer Center 12
National Cancer Institute (NCI) 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sprycel
Sponsor Trials
Other 58
Industry 39
NIH 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Boehringer Ingelheim
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.